Angiogenic Acceleration of Neu Induced Mammary Tumor Progression and Metastasis

Cancer Research

Volumn 64, Issue 1, 2004, Pages 169-179

  Oshima, Robert G ^a,b   Lesperance, Jacqueline ^a   Munoz, Varinia ^a   Hebbard, Lionel ^a   Ranscht, Barbara ^a   Sharan, Niki ^b   Muller, William J ^c   Hauser, Craig A ^a   Cardiff, Robert D ^d  

^a BURNHAM INSTITUTE   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CELL JUNCTION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENETIC ANALYSIS; HYPOXIA; IN VIVO STUDY; LUNG; MAMMARY GLAND FUNCTION; METASTASIS; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TUMOR GROWTH; VASCULARIZATION;

ANIMALS; BASE SEQUENCE; DISEASE PROGRESSION; DNA PRIMERS; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1642453824     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1944     Document Type: Article

References (44)

1. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54: 105-115, 1988.
2. Siegel, P. M., Hardy, W. R., and Muller, W. J. Mammary gland neoplasia: insights from transgenic mouse models. Bioessays, 22: 554-563, 2000.
3. Dankort, D., Jeyabalan, N., Jones, N., Dumont, D. J., and Muller, W. J. Multiple ErbB2/Neu phosphorylation sites mediate transformation through distinct effector proteins. J. Biol. Chem., 276: 38921-38928, 2001.
4. Dankort, D., Maslikowski, B., Warner, N., Kanno, N., Kim, H., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., and Muller, W. J. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB2)-induced mammary tumorigenesis: implications for human breast cancer. Mol. Cell. Biol., 21: 1540-1551, 2001.
5. Khoury, H., Dankort, D. L., Sadekova, S., Naujokas, M. A., Muller, W. J., and Park, M. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB2/Neu receptor. Oncogene, 20: 788-799, 2001.
6. Gale, N. W., and Yancopoulos, G. D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev., 13: 1055-1066, 1999.
7. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. Vascular-specific growth factors and blood vessel formation. Nature (Lond.), 407: 242-248, 2000.
8. Grunstein, J., Masbad, J. J., Hickey, R., Giordano, F., and Johnson, R. S. Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol. Cell. Biol., 20: 7282-7291, 2000.
9. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., and McDonald, D. M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science (Wash. DC), 286: 2511-2514, 1999.
10. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
11. Inoue, M., Hager, J. H., Ferrara, N., Gerber, H. P., and Hanahan, D. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic β cell carcinogenesis. Cancer Cell, 1: 193-202, 2002.
12. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol., 2: 737-744, 2000.
13. Gannon, G., Mandriota, S. J., Cui, L., Baetens, D., Pepper, M. S., and Christofori, G. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during β-cell carcinogenesis. Cancer Res., 62: 603-608, 2002.
14. Coussens, L. M., Raymond, W. W., Berger, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., and Hanahan, D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev., 13: 1382-1397, 1999.
15. Yen, L., You, X. L., Al Moustafa, A. E., Batist, G., Hynes, N. E., Mader, S., Meloche, S., and Alaoui-Jamali, M. A. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene, 19: 3460-3469, 2000.
16. Rak, J., Mitsuhashi, Y., Sheehan, C., Tamir, A., Viloria-Petit, A., Filmus, J., Mansour, S. J., Ahn, N. G., and Kerbel, R. S. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res., 60: 490-498, 2000.
17. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., and Semenza, G. L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol., 21: 3995-4004, 2001.
18. Siegel, P. M., Ryan, E. D., Cardiff, R. D., and Muller, W. J. Elevated expression of activated forms of Neu/ErbB2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J., 18: 2149-2164, 1999.
19. Webster, M. A., Hutchinson, J. N., Rault, M. J., Muthuswamy, S. K., Anton, M., Tortorice, C. G., Cardiff, R. D., Graham, F. L., Hassell, J. A., and Muller, W. J. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol., 18: 2344-2359, 1998.
20. Saaristo, A., Karpanen, T., and Alitalo, K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene, 19: 6122-6129, 2000.
21. Liotta, L. A., and Kohn, E. C. The microenvironment of the tumour-host interface. Nature (Lond.), 411: 375-379, 2001.
22. Sugino, T., Kusakabe, T., Hoshi, N., Yamaguchi, T., Kawaguchi, T., Goodison, S., Sekimata, M., Homma, Y., and Suzuki, T. An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am. J. Pathol., 160: 1973-1980, 2002.
23. Sympson, C. J., Talhouk, R. S., Alexander, C. M., Chin, J. R., Clift, S. M., Bissell, M. J., and Werb, Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol., 125: 681-693, 1994.
24. Wen, F., Cecena, G., Munoz-Ritchie, V., Fuchs, E., Chambon, P., and Oshima, R. G. Expression of conditional cre recombinase in epithelial tissues of transgenic mice. Genesis, 35: 100-106, 2003.
25. Soemarwoto, I. N., and Bern, H. A. The effects of hormones on the vascular pattern of the mouse mammary gland. Am. J. Anat., 103: 403-435, 1958.
26. Trevor, K., and Oshima, R. G. Preimplantation mouse embryos and liver express the same type I keratin gene product. J. Biol. Chem., 260: 15885-15891, 1985.
27. Braissant, O., and Wahli, W. Differential expression of peroxisome proliferator-activated receptor-α, -β, and -γ during rat embryonic development. Endocrinology, 139: 2748-2754, 1998.
28. Chomenzski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
29. Rozen, S., and Skaletsky, H. Primer3 on the WWW for general users and for biologist programmers. In: S. Krawetz and S. Misener (eds.). Bioinformatics Methods and Protocols: Methods in Molecular Biology, pp. 365-386. Totowa, New Jersey: Humana Press, 2000.
30. Feroze-Merzoug, F., Berquin, I. M., Dey, J., and Chen, Y. Q. Peptidylprolyl isomerase A (PPIA) as a preferred internal control over GAPDH and β-actin in quantitative RNA analyses. Biotechniques. 32: 776-778, 780, 782, 2002.
31. Korpelainen, E. I., Karkkainen, M. J., Tenhunen, A., Lakso, M., Rauvala, H., Vierula, M., Parvinen, M., and Alitalo, K. Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. J. Cell Biol., 143: 1705-1712, 1998.
32. Muthuswamy, S. K., Li, D., Lelievre, S., Bissell, M. J., and Brugge, J. S. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol., 3: 785-792, 2001.
33. Bissell, M. J., and Bilder, D. Polarity determination in breast tissue: desmosomal adhesion, myoepithelial cells, and laminin I. Breast Cancer Res., 5: 117-119, 2003.
34. Bilder, D. Li, M., and Perrimon, N. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science (Wash. DC), 289: 113-116, 2000.
35. Hoover, K. B., Liao, S. Y., and Bryant, P. J. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am. J. Pathol., 153: 1767-1773, 1998.
36. Kominsky, S. L., Argani, P., Korz, D., Evron, E., Raman, V., Garrett, E., Rein, A., Sauter, G., Kallioniemi, O. P., and Sukumar, S. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene, 22: 2021-2033, 2003.
37. Nunbhakdi-Craig, V., Machleidt, T., Ogris, E., Bellotto, D., White, C. L. III, and Sontag, E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J. Cell Biol., 158: 967-978, 2002.
38. Ranscht, B., and Dours-Zimmermann, M. T. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron, 7: 391-402, 1991.
39. Wyder, L., Vitaliti, A., Schneider, H., Hebbard, L. W., Moritz, D. R., Wittmer, M., Ajmo, M., and Klemenz, R. Increased expression of H/T-cadherin in tumor-penetrating blood vessels. Cancer Res., 60: 4682-4688, 2000.
40. Ryan, H. E., Lo, J., and Johnson, R. S. HIF-1 α is required for solid tumor formation and embryonic vascularization. EMBO J., 17: 3005-3015, 1998.
41. Murakami, T., Nishiyama, T., Shirotani, T., Shinohara, Y., Kan, M., Ishii, K., Kanai, F., Nakazuru, S., and Ebina, Y. Identification of two enhancer elements in the gene encoding the type I glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J. Biol. Chem., 267: 9300-9306, 1992.
42. Dang, C. V., and Semenza, G. L. Oncogenic alterations of metabolism. Trends Biochem. Sci., 24: 68-72, 1999.
43. Mamluk, R., Gechtman, Z., Kutcher, M. E., Gasiunas, N., Gallagher, J., and Klagsbrun, M. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its blb2 domain. J. Biol. Chem., 277: 24818-24825, 2002.
44. Bachelder, R. E., Crago, A., Chung, J., Wendt, M. A., Shaw, L. M., Robinson, G., and Mercurio, A. M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res., 61: 5736-5740, 2001.